Otsuka sees 'the other side of personal medicine' in Proteus deal for cancer and CNS
This article was originally published in Scrip
Executive Summary
In another sign of the blurring boundaries between therapeutics and medical technology, Otsuka Pharmaceutical has put down its marker in the area of drug compliance management, linking up with Proteus Digital Health for the joint development and commercialisation of "digital medicines."